NASDAQ:BLUE
bluebird bio Stock News
$0.97
-0.0354 (-3.50%)
At Close: May 08, 2024
bluebird bio Inc (NASDAQ:BLUE) Shares Sold by Capital Bank & Trust Co
10:34am, Sunday, 29'th Mar 2020
Capital Bank & Trust Co lowered its position in shares of bluebird bio Inc (NASDAQ:BLUE) by 99.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned
bluebird bio Inc (NASDAQ:BLUE) Shares Bought by Advisor Group Inc.
08:22am, Sunday, 29'th Mar 2020
Advisor Group Inc. increased its holdings in bluebird bio Inc (NASDAQ:BLUE) by 143.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Co
Hedge Funds Have Never Been This Bullish On Brunswick Corporation (BC)
01:35am, Sunday, 29'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Stocks To Watch: Investors Stay The Distance
01:04pm, Saturday, 28'th Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More
02:03pm, Friday, 27'th Mar 2020
Finding and enrolling patients for clinical trials is always challenging. The coronavirus pandemic has made it nearly impossible. Fallout from the spread
Stifel likes bluebird bio in premarket analyst action
11:04am, Friday, 27'th Mar 2020
Calithera Biosciences (NASDAQ:CALA) initiated with Buy rating and $6 (34% upside) price target at Jefferies.Bluebird bio (NASDAQ:BLUE) upgraded to Buy with a $70 (50% upside) price target at Stifel.Ch
